There is a field of research, Pharmacogenetics/Pharmacogenomics, that is rising to prominence, as we speak. St. Jude’s Children Hospital, the Mayo Clinic are some of the institutions leading the charge. Turns out that one size doesn’t fit all, after all. Vaccines contain excipients that must be metabolized by the liver’s superfamily of enzymes (Cytochrome P450).
Let’s take my family, for example. We are a typical middle – upper class, educated Caucasian family. We eat virtually only organic food. We meditate and are generally so healthy that we don’t have a family physician as we rarely have a need to go to a doctor. We are a combination of strong stock: Irish, Swedish, Polish, Danish. Our last child, a boy, was born in 1984. During that time until 2001, 15 of the 39 or so vaccines contained a mercury compound known as Thimerosal. This “heavy metal” compound was removed from all the vaccines in and around 2001 with the exception of the multidose flu vaccine that was distributed in the general clinics, to Medicaid dependent children and pregnant women of all stripes. However, by that time I had educated myself about the risks and benefits of vaccines. So, I did not vaccinate David.
At the age of 18, David went to the University of Iowa, similar to most colleges where prescription drugs are ubiquitous. Adderall was easily obtained, gladly shared by students who had been on Adderall in middle school and high school, some began as early as 5 years old. One day David, experimented in this revival ‘60s millennium drug culture with one dose of LSD.
Video Message to Dr. Yolande Lucire from David IMG_0044
Since its approval in October of 2017, Shingrix vaccine has overshadowed the older Zostavax vaccine produced by Merck, which had been the only shingles vaccine available in the U.S. for more than a decade. Shingrix is reported to be up to 90 percent effective in preventing the development of shingles, compared to an estimated 50 percent effectiveness for Zostavax.3
In June, the Centers for Disease Control and Prevention (CDC) published a report discussing a significant number of administrative errors and serious injuries associated with the new shingles vaccine.4
I have written about the failure of the older vaccine-Zostavax—for many years in both my blog posts and my Natural Way to Health Newsletter. In those articles, I show you that Zostavax fails nearly 99% who take it. Naturally, anything that fails 99% who take it, should not be prescribed.
The ARR for this study can be calculated here: 3%-0.08%=2.9%. Therefore, a more appropriate determination of the effectiveness of Shingrix is that it is 2.9% effective at preventing shingles for a median of 3.1 years (the length of the study). And, a true statement about Shingrix is that it takes 34 people to be vaccinated with Shingrix (1/2.9%) to prevent one case of shingles. That means the drug failed 33 out of 34 who took it which is a 97% failure rate!
Yes, shingles is a horrible illness. I had it a year ago. A great treatment for shingles is ozone injections into the nerve root where shingles is occurring. It works nearly every time if it is done within a few days of the onset of the illness. Also, taking vitamin C (5-10,000mg/day) and L-lysine (1,000mg three times per day) helps.
So, Shingrix is certainly better than Zostavax since Zostavax fails 99% who take it. READ MORE...
My name is Christy and I’m a full-time mother to two beautiful children, one who happens to have special needs. I’m also owner and writer for wondermoms.org where I love passing on my knowledge and insights to others in the community. Recently I’ve been pondering what life will be like for my non-verbal 6-year-old son when he turns 18. I’m positive he won’t be able to just go off on his own as he transitions into adulthood.
I thought I’d pass along some additional resources I found. Hopefully, they can help families deal with this scary time in their lives and find it useful.
Contrary to conventional wisdom, brain regeneration is possible. One promising therapy that promotes neurogenesis and is effective in pre-clinical studies of Alzheimer’s and Parkinson’s is near infrared light therapy, and
it may improve other mental illnesses and neurodegenerative disorders including dementia, stroke, ALS, and traumatic brain injury as well.
VLA COMMENT: L Ron Hubbard, many years ago devised a program of detoxification of drugs and medication, In his book, ClearMind/ClearBodyhe states that these elements are sequestered by the fatty tissue. Narconon, a detoxification center prescribes for adults 4 hours of sauna at 130-150 degrees while jogging and exercising beforehand to loosen up the crystals embedded in the fatty tissue. Niacin (not Niacin Amide) is taken before the sauna and increase upward to as much as 5000 mgs. Hubbard also includes oils and nutrition as stated in the above program…oils to replace the fat being lost. He says running and SWEATING is virtually the only way to remove the toxins from the fatty tissue. I have used this technique with great success for ridding adults of drug, medication toxins.
Non-invasive therapy to reduce the body
burden of aluminium in Alzheimer’s disease
Abstract. There are unexplained links between human exposure to aluminium and the incidence, progression and aetiology of Alzheimer’s disease. The null hypothesis which underlies any link is that there would be no Alzheimer’s disease in the effective absence of a body burden of aluminium. To test this the latter would have to be reduced to and retained at a level that was commensurate with an Alzheimer’s disease-free population. In the absence of recent human interference in the biogeochemical cycle of aluminium the reaction of silicic acid with aluminium has acted as a geochemical control of the biological availability of aluminium. This same mechanism might now be applied to both the removal of aluminium from the body and the reduced entry of aluminium into the body while ensuring that essential metals, such as iron, are unaffected. Based upon the premisethat urinary aluminium is the best non-invasive estimate of body burden of aluminium patients with Alzheimer’s disease were asked to drink 1.5 L of a silicic acid-rich mineral water each day for five days and, by comparison of their urinary excretion of aluminium pre-and post this simple procedure, the influence upon their body burden of aluminium was determined. Drinking the mineral water increased significantly (P <0.001) their urinary excretion of silicic acid (34.3 ± 15.2 to 55.7 ± 14.2 μmol/mmol
creatinine) and concomitantly reduced significantly (P = 0.037) their urinary excretion of aluminium (86.0 ± 24.3 to 62.2 ± 23.2 nmol/mmol creatinine). The latter was achieved without any significant (P >0.05) influence upon the urinary excretion of iron (20.7 ± 9.5 to 21.7 ± 13.8 nmol/mmol creatinine). The reduction in urinary aluminium supported the future longer-term
use of silicic acid as non-invasive therapy for reducing the body burden of aluminium in Alzheimer’s disease.